share_log

Susquehanna Maintains Negative on RXO, Raises Price Target to $16

Moomoo 24/7 ·  Mar 25 08:57

Susquehanna analyst Bascome Majors maintains RXO (NYSE:RXO) with a Negative and raises the price target from $15 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment